SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC - GALMED PHARMACEUTICALS LTD ownership

Back to all holdings Add to watchlist

GALMED PHARMACEUTICALS LTD's ticker is GLMD and the CUSIP is M47238106. A total of 26 filers reported holding GALMED PHARMACEUTICALS LTD in Q3 2021. The put-call ratio across all filers is 6.10 and the average weighting 0.1%.

Links
Filings
External links
Quarter-by-quarter ownership
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC ownership history of GALMED PHARMACEUTICALS LTD
ValueSharesWeighting
Q2 2021$31,000
-24.4%
10,200
-14.3%
0.00%0.0%
Q1 2021$41,000–11,900–0.00%–
 Download
Other shareholders

There were no reported owners of GALMED PHARMACEUTICALS LTD in Q3 2021.

NameSharesValueWeighting ↓
View complete list of GALMED PHARMACEUTICALS LTD shareholders